Clare Ozawa - Profile and Investment Details

Investor Profile

Clare Ozawa is a Venture Capital based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics, Aprea, CODA Biotherapeutics, Therachon, Inception IBD, Monteris Medical, Zyga Technology, Inari Medical, Century Therapeutics, Ceterix Orthopaedics, Audentes Therapeutics, Gotham Therapeutics, GenSight Biologics, Matterhorn Biosciences, Ventus Therapeutics, Benvenue Medical, Pandion Therapeutics, T-knife, Vividion Therapeutics, NeuWave Medical, PIQUR Therapeutics, Tarveda Therapeutics, VectivBio, Akero Therapeutics, Crinetics Pharmaceuticals, Graphite Bio, Jecure Therapeutics, RayzeBio, BlueRock Therapeutics, Sebacia, Repare Therapeutics, Enterprise Therapeutics, Kinestral Technologies, Intuity Medical, Metavention, Tempest Therapeutics, Bright Peak Therapeutics, Veran Medical Technologies, Respicardia, Nouscom, Nuvaira, Quentis Therapeutics, Passage Bio, Turnstone Biologics, Oyster Point Pharmaceuticals, Chinook Therapeutics, Monte Rosa Therapeutics, Pipeline Therapeutics, Twelve, Venatorx Pharmaceuticals, Gritstone Oncology, Jnana, Ebb Therapeutics, Lava Therapeutics, ROX Medical, AcuFocus, Anokion, Ivantis, Laguna Pharmaceuticals. Over time, Clare Ozawa has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Clare Ozawa is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Women Founded, Medical Testing, Life Science, Biotech, Medical Device, Healthcare, Biotechnology, Genomics, Health Diagnostics, Medical, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Clare Ozawa, as their portfolio suggests a familiarity and interest in this area.

Understanding Clare Ozawa’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.